Which Patient Factors And Contraindications Must Aesthetic Practitioners Screen For Before Ablative Laser Skin Resurfacing? Essential Screening Checklist

Before ablative laser resurfacing, practitioners should screen for anything that can impair re-epithelialization, increase infection or scarring risk, trigger inflammatory disease, or make postoperative care unsafe. The key history includes recent oral isotretinoin, keloids or hypertrophic scars, prior radiation or significant burns, immunodeficiency or immunosuppression, collagen vascular disease, active infection, Koebnerizing dermatoses, smoking, relevant eyelid surgery, skin phototype, and the patient’s ability to follow wound-care instructions.

Ablative resurfacing is controlled wound creation. Patients with impaired healing, active infection, abnormal scarring tendencies, unstable inflammatory disease, or unrealistic expectations require postponement, modified treatment, specialist input, or an alternative procedure.

Screen for Factors That Impair Wound Healing

Recent oral isotretinoin use

Ask specifically about oral isotretinoin and other systemic retinoids, including the dose and date of the last course.

For deep or fully ablative procedures, many clinicians defer treatment for at least 6 months, and sometimes 6–12 months, after isotretinoin. The appropriate interval should follow current evidence, specialty guidance, and the planned depth of ablation because the main concern is delayed healing and abnormal scarring.

History of keloids or hypertrophic scars

A personal history of keloids, hypertrophic scars, or poor healing after surgery, piercings, burns, or acne is a major warning sign.

This history increases the risk of excessive scar formation after laser-induced injury and may make deep ablative resurfacing unsuitable, particularly when the patient has previously formed scars in cosmetically important areas.

Previous radiation, burns, or deep chemical injury

Ask about radiation therapy at or near the treatment site, significant burn scars, and previous deep phenol or similar chemical peels.

Radiation and severe prior tissue injury can damage epidermal stem-cell reservoirs, hair follicles, adnexal structures, and local vascularity. These structures contribute to re-epithelialization, so healing may be delayed or unpredictable.

Immunodeficiency and immunosuppressive therapy

Review the history for HIV or other immunodeficiency, organ transplantation, hematologic disease, chemotherapy, chronic corticosteroid use, biologic agents, and other immunosuppressive medications.

The concern is increased susceptibility to bacterial, viral, or fungal infection and reduced ability to repair the ablated surface. The decision should account for disease control, laboratory data when relevant, and coordination with the treating specialist.

Diabetes and other systemic disease

Screen for unstable or poorly controlled diabetes, significant cardiovascular disease, uncontrolled hypertension, and other illnesses that could compromise anesthesia, perfusion, immune function, or postoperative care.

These conditions are not automatically disqualifying in every case, but unstable disease should be controlled before elective deep resurfacing.

Smoking and vascular compromise

Ask about current cigarette or nicotine use, heavy vaping, peripheral vascular disease, and other causes of impaired tissue perfusion.

Smoking can reduce oxygen delivery and compromise healing, increasing the risk of delayed recovery, infection, necrosis, and poor scarring. Elective treatment should generally be postponed until the patient can safely stop or reduce exposure according to the clinician’s protocol.

Identify Conditions That Can Worsen With Resurfacing

Collagen vascular and autoimmune disease

Screen for systemic lupus erythematosus, scleroderma, Sjögren syndrome, and other collagen vascular or autoimmune disorders.

These conditions may affect inflammation, vascularity, collagen remodeling, and wound repair. Active or poorly controlled disease is a strong reason to defer treatment; even stable disease may require specialist consultation and conservative treatment planning.

Koebnerizing skin diseases

Ask about psoriasis, vitiligo, lichen planus, active eczema, and other disorders that can appear at sites of trauma.

Ablative injury may provoke new lesions through the Koebner phenomenon. Active or unstable disease at or near the treatment area is generally a reason to postpone resurfacing until adequately controlled.

Active inflammatory skin disease

Do not treat through active dermatitis, acneiform inflammation, rosacea flares, ulceration, or other significant inflammatory skin conditions without first addressing the underlying problem.

Inflamed skin may heal less predictably and can develop worsening inflammation, pigment alteration, or scarring after ablation.

Exclude Infection and Plan for Herpes Risk

Active bacterial, viral, or fungal infection

An active infection in the treatment area is a contraindication until it has resolved.

This includes impetigo, cellulitis, fungal infection, active herpes lesions, and other contagious or ulcerative eruptions. Ablation removes the protective epidermal barrier and can facilitate spread or severe postoperative infection.

History of herpes simplex

A history of herpes labialis or recurrent perioral herpes is not necessarily a reason to exclude treatment, but it requires a prevention plan.

For full-face or perioral resurfacing, practitioners commonly prescribe prophylactic oral antiviral therapy, such as acyclovir or valacyclovir, beginning on or before treatment and continuing through the period specified by the clinical protocol, often approximately 7–10 days.

The patient should also understand the symptoms of reactivation and how to obtain prompt treatment.

Evaluate Procedure-Specific Surgical History

Prior external lower blepharoplasty

Ask about previous external lower blepharoplasty, especially when infraorbital or lower-eyelid resurfacing is planned.

This history can increase the risk of postoperative ectropion, particularly when combined with aggressive ablation, eyelid laxity, or excessive contraction during healing. The treatment area and energy settings may need modification, or the procedure may be inappropriate.

Other procedures and tissue injury

Review prior facial surgery, scars, implants, grafts, trauma, and procedures that may have altered local anatomy or blood supply.

The significance depends on the location, depth, timing, and planned laser field. When anatomy or healing capacity is uncertain, a focused examination and specialist assessment are appropriate.

Assess Phototype and Pigment Risk

Fitzpatrick skin type

Document the patient’s Fitzpatrick phototype, with particular attention to types IV–VI.

Darker phototypes have a higher risk of post-inflammatory hyperpigmentation, prolonged erythema, hypopigmentation, and visible treatment demarcation. This is a risk factor rather than an automatic contraindication, but it may favor less aggressive settings, fewer passes, fractional treatment, or an Er:YAG approach.

History of dyschromia

Ask whether the patient has previously developed hyperpigmentation or hypopigmentation after acne, surgery, burns, peels, or other procedures.

A prior tendency toward pigmentary change should shape consent, sun-avoidance counseling, treatment intensity, and the choice of device or technique.

Confirm the Patient Can Safely Complete Recovery

Ability to follow wound care

Determine whether the patient can reliably perform cleansing, occlusive or prescribed wound care, medication use, sun avoidance, follow-up visits, and infection monitoring.

Inability or unwillingness to comply with postoperative care is a practical contraindication because the risk of infection, delayed healing, pigment alteration, and scarring increases substantially.

Expectations and motivation

Screen for unrealistic expectations, pressure from others, inability to accept downtime, or misunderstanding of the likely result.

Ablative resurfacing can improve texture, rhytids, and selected scars, but it does not eliminate all wrinkles or replace surgical correction. Treatment should be deferred when informed consent is incomplete or expectations cannot be aligned with achievable outcomes.

Understanding the Trade-offs

Not every risk factor is an absolute contraindication

Some findings require cancellation, while others require modification or specialist input.

Usually postpone or avoid: active infection, active uncontrolled inflammatory disease, significant inability to provide wound care, and a strong history of abnormal scarring for deep ablation.
Usually require individualized assessment: stable autoimmune disease, prior radiation or burns, immunosuppression, smoking, darker phototype, prior eyelid surgery, and controlled systemic illness.
Require preventive planning rather than automatic exclusion: prior herpes simplex without active lesions, provided antiviral prophylaxis and follow-up are appropriate.

“Recent isotretinoin” requires protocol-specific judgment

The traditional approach is to wait 6 months or longer before deep ablative resurfacing. Evidence regarding all laser procedures is more nuanced, so the interval should not be applied mechanically across every device and treatment depth.

For aggressive CO₂ or other fully ablative treatment, a conservative waiting period and careful documentation remain prudent.

Higher phototype does not mean treatment is impossible

Patients with darker skin can sometimes be treated safely, but the risk of dyschromia is higher.

The practitioner must balance the desired correction against treatment intensity, device selection, test-spot strategy where appropriate, strict photoprotection, and the patient’s tolerance for pigmentary complications.

Making the Right Choice for Your Goal

Use the screening history to decide whether to proceed, modify the technique, postpone treatment, or refer for additional assessment.

If your primary focus is wound-healing safety: Defer treatment for recent isotretinoin, active infection, uncontrolled systemic disease, major immunosuppression, or tissue previously damaged by radiation or severe burns.
If your primary focus is minimizing abnormal scarring: Treat a history of keloids or hypertrophic scars as a major risk factor and avoid aggressive ablation unless the indication and specialist assessment justify it.
If your primary focus is preventing viral complications: Ask about recurrent herpes simplex and arrange appropriate antiviral prophylaxis for full-face or perioral resurfacing.
If your primary focus is pigment control: Document Fitzpatrick phototype and prior dyschromia, then consider conservative settings, fractional or Er:YAG treatment, and rigorous sun protection for higher-risk patients.
If your primary focus is avoiding anatomic complications: Identify prior external lower blepharoplasty and other facial surgery before treating the eyelids or infraorbital region.
If your primary focus is predictable outcomes: Confirm realistic expectations, informed consent, and the patient’s ability to complete postoperative wound care before scheduling treatment.

Safe ablative resurfacing begins with selecting the right patient, not simply choosing the right laser settings.

Summary Table:

Factor	Concern	Action
Recent oral isotretinoin	Delayed healing, scarring	Defer 6-12 months for deep ablation
Keloids/hypertrophic scars	Abnormal scarring, keloids	Avoid deep ablation; consider alternatives
Prior radiation/burns	Poor vascularity, stem cell damage	Assess carefully; modify or avoid
Immunosuppression	Infection risk, poor healing	Defer until controlled; specialist input
Unstable diabetes/systemic disease	Impaired healing, complications	Control before elective treatment
Smoking/vascular compromise	Reduced perfusion, necrosis	Stop/reduce before treatment
Collagen vascular/autoimmune disease	Inflammation, poor remodeling	Defer if active; consult specialist
Koebnerizing dermatoses (psoriasis, etc.)	Trauma-induced lesions	Defer until controlled
Active infection	Spread, severe infection	Treat first; defer until resolved
History herpes simplex	Reactivation, dissemination	Use antiviral prophylaxis
Prior external lower blepharoplasty	Ectropion risk	Modify treatment or avoid
Fitzpatrick IV-VI	Hyper/hypopigmentation	Conservative settings, test spots
Poor wound-care compliance	Complications	Defer; educate patient
Unrealistic expectations	Dissatisfaction	Align expectations or defer

Ready to enhance your practice with safe, effective laser resurfacing? At BELIS, we offer professional-grade aesthetic equipment for clinics and premium salons. Our advanced portfolio includes CO₂ fractional, Erbium, and other laser systems designed to deliver optimal results while prioritizing patient safety. Contact us today to learn how BELIS can support your clinical excellence and patient satisfaction — Get in touch with our experts!